TS
Todd Sone
Investor at Scipher Medicine
TS
Todd Sone
Investor at Scipher Medicine
Israel
Overview
Work Experience
General Partner
2021 - Current
Partnering with great HealthTech entrepreneurs.
Partner
2017 - 2021
Investor & Board Observer
2018
Bringing the $100 genome to market.
Investor & Board Director
2021
Using biomarkers to reduce trial & error and help physicians make informed treatment decisions.
Investor & Board Director
2020
The longer the track, the greater the separation of the field.
Investor & Board Director
2019
Treating migraine (better) without drugs and without looking like a Klingon.
Investor & Board Director
2019
Designing and developing antibodies using proprietary 3D modelling.
Investor & Board Director
2018
Finding that polyp (better).
Investor & Board Director
2018 - 2021
Clinical-stage precision oncology company with a lead asset in Ph 2 trials for desmoid tumor.
Partner
2009 - 2017
Growth capital to innovative healthcare companies.
Investor
2012 - 2017
Specialty pharma focused on injectable and infusion medications. Sold to Baxter.